Therapy With Different Dose Regimens of Rituximab in Patients With Active Moderate-To-Severe Graves’ Orbitopathy [PDF]
Frontiers in Endocrinology, 2022 BackgroundImmunosuppressive therapy of Graves’ orbitopathy (GO) is indicated during the active phase of disease. Intravenous steroids (IVGC) are effective in about 70% of patients, although unresponsiveness or relapse are observed.
Irene Campi +16 more
doaj +3 more sources
Color Doppler imaging of the superior ophthalmic vein in patients with Graves' orbitopathy before and after treatment of congestive disease [PDF]
Clinics, 2011 OBJECTIVE: To compare superior ophthalmic vein blood flow parameters measured with color Doppler imaging in patients with congestive Graves' orbitopathy before and after treatment and in normal controls.
Mário L. R. Monteiro +3 more
doaj +4 more sources
Not All Orbitopathy Is Graves’: Discussion of Cases and Review of Literature
Frontiers in Endocrinology, 2017 IntroductionGraves’ orbitopathy is the extra thyroidal manifestation of Graves’ disease and the most common cause of exophthalmos. It is also known as thyroid-associated orbitopathy (TAO) as it occasionally occurs in euthyroid or hypothyroid patients ...
Vibhor Wadhwa, Gitanjali Bajaj
exaly +3 more sources
Orbital Signaling in Graves’ Orbitopathy [PDF]
Frontiers in Endocrinology, 2021 Graves’ orbitopathy (GO) is a complex and poorly understood disease in which extensive remodeling of orbital tissue is dominated by adipogenesis and hyaluronan production.
Mohd Shazli Draman +4 more
doaj +2 more sources
Frontiers in Endocrinology, 2022 ObjectiveManagement of Graves’ orbitopathy remains a challenge. Our previous case report has shown promising results for rabbit antithymocyte globulin (rATG) in the treatment of Graves’ orbitopathy.DesignWe present the response of 7 individuals with ...
Monika Sarnat-kucharczyk +1 more
exaly +3 more sources
Unilateral Graves' Orbitopathy in a Patient with Marine-Lenhart Syndrome: A case report. [PDF]
Sultan Qaboos Univ Med JThyroid eye disease (TED) is the most common symptoms of Graves’ disease. This condition commonly manifests bilaterally and symmetrically. The most prominent symptoms are lid retraction, exophthalmos, and diplopia.
Alfutaisi A +6 more
europepmc +3 more sources
Steroid-resistant Graves' orbitopathy: Therapeutic options [PDF]
Medicinski Glasnik Specijalne Bolnice za Bolesti Štitaste Žlezde i Bolesti Metabolizma "Zlatibor", 2023 Graves orbitopathy is the most common extrathyroidal manifestation of autoimmune hyperthyroidism, although it can rarely occur in euthyroid and hypothyroid patients.
Klet Sanja +6 more
doaj +1 more source
Management of patients with Graves' disease and orbital involvement: role of spectral domain optical coherence tomography [PDF]
, 2018 PURPOSE: To investigate the role of choroidal thickness evaluation with spectral domain optical coherence tomography (SDOCT) and enhanced depth imaging (EDI) technique in the management of patients with Graves' disease and orbitopathy (GO).
Bruscolini, A +7 more
core +1 more source
Extraocular muscle sampled volume in Graves' orbitopathy using 3-T fast spin-echo MRI with iterative decomposition of water and fat sequences [PDF]
, 2018 Background: Current magnetic resonance imaging (MRI) techniques for measuring extraocular muscle (EOM) volume enlargement are not ideally suited for routine follow-up of Graves’ ophthalmopathy (GO) because the difficulty of segmenting the muscles at ...
BRUSCOLINI, ALICE +4 more
core +1 more source